Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Revenue (2012 - 2026)

Updated

Grace Therapeutics (GRCE) posted Revenue of $141,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 30.9% from $204,000 a year earlier but up 2.2% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Revenue (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Grace Therapeutics was $623,000, down 10.6% year-over-year; for FY2026 (ended Mar 31, 2026), it was $685,000, down 5.9% from FY2025.

  • Annual Revenue shows a five-year compound annual growth rate of 28.4% (FY2021 to FY2026).
  • In prior fiscal years, Grace Therapeutics' Revenue was $728,000 in FY2025 (-16.8%) and $875,000 in FY2024.
  • Quarterly Revenue has run from a low of $127,000 in fiscal Q3 2025 to a high of $235,000 in fiscal Q1 2025 over five years.
  • On a year-over-year basis, Revenue increased in 1 of the last five quarters, with an average decline of 7.8%.
  • According to Business Quant data, Revenue for the three prior fiscal quarters was $138,000 (Q4 2026), $172,000 (Q3 2026) and $172,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 25.40 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 17.40 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 15.07 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 8.30 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 16.58 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 154,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141,000.00
Mar 31, 2026 138,000.00
Dec 31, 2025 172,000.00
Sep 30, 2025 172,000.00
Jun 30, 2025 204,000.00
Mar 31, 2025 184,000.00
Dec 31, 2024 127,000.00
Sep 30, 2024 182,000.00
Jun 30, 2024 235,000.00
Mar 31, 2021 115,000.00
Dec 31, 2020 81,000.00
Mar 31, 2018 1.17 Mn
Dec 31, 2017 -960,313.54
Sep 30, 2017 -116,421.33
Nov 30, 2016 1.26 Mn
Aug 31, 2016 3,651.00
May 31, 2016 2,888.00
Nov 30, 2015 5,074.00
Aug 31, 2015 6,999.00
May 31, 2015 5,154.00
API Access

Grace Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GRCE&period=max&api_key=YOUR_API_KEY